oral semaglutide nejm New in the May 29, 2025, issue of NEJM: Sotatercept in Pulmonary Arterial Hypertension (ZENITH phase 3 trial) https://nej.md/4iYkLbj and Cardiovascular Outcomes (SOUL trial) https://nej.md/4hHII5M Upadacitinib for Giant-Cell Arteritis Oral Semaglutide and Cardiovascular Outcomes

Get the Care You Need, When You Need It Whether youre home with a cold, traveling for work, or simply too busy to make it to the doctors office, your health benefits through the Joint Health Management Board (JHMB) make accessing care easier by including no-cost telehealth visits with Teladoc

The review concludes that future research must establish evidence-based screening protocols, determine optimal glucose nadir cut-off values for diagnosis, and evaluate long-term outcomes for offspring exposed to maternal hypoglycemia.

S-Factor2 is a great way to lose weight with Semaglutide and B12

Shortages of drugs like Adderall are growing in the United States, and experts see no clear path to resolving them.

Rapid fat loss can reduce facial volume, affect skin elasticity, and increase hair shedding

Start your journey to better health today.